Literature DB >> 6806260

Oxidation of phenidone and BW755C by prostaglandin endoperoxide synthetase.

L J Marnett, P H Siedlik, L W Fung.   

Abstract

1-Phenyl-3-pyrazolidone (phenidone) and 3-amino-1-(m-(trifluoromethyl)-phenyl)-2-pyrazoline (BW755C) are oxidized by the hydroperoxidase component of prostaglandin endoperoxide synthetase and by horseradish peroxidase. The initial oxidation products are radical cations which exhibit visible absorption maxima at 514, 490, and 472 nm (phenidone) and 535, 500, and 488 nm (BW755C). The radical cation of phenidone can be detected by electron paramagnetic resonance spectroscopy as a complex multiline signal centered at g = 2.0039. In addition to being oxidized by peroxidases both compounds are cofactors for the reduction of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid to 15-hydroxy-5,8,11,13-eicosatetraenoic acid by the hydroperoxidase activity of purified and hematin-reconstituted prostaglandin endoperoxide synthetase. As a consequence of their oxidation by prostaglandin endoperoxide synthetase, phenidone and BW755C inhibit the hydroperoxide-dependent oxidation of phenylbutazone, luminol, diphenylisobenzofuran, epinephrine, and guaiacol by ram seminal vesicle microsomes. The inhibition of phenylbutazone oxidation is competitive and exhibits Ki values of 16 microM (BW755C) and 45 microM (phenidone). BW755C and phenidone stimulate prostaglandin biosynthesis by purified and reconstituted prostaglandin endoperoxide synthetase at concentrations up to 100 microM but inhibit at higher concentrations (I50 values approximately 210 microM and 1180 microM, respectively). The ability of phenidone and BW755C to act as peroxidase reducing cofactors or radical scavengers may contribute to their observed biochemical and pharmacological effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806260

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor.

Authors:  S Moncada; R M Palmer; R J Gryglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation.

Authors:  P A Craven; J Pfanstiel; F R DeRubertis
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Inhibition by Salicylhydroxamic Acid, BW755C, Eicosatetraynoic Acid, and Disulfiram of Hypersensitive Resistance Elicited by Arachidonic Acid or Poly-l-Lysine in Potato Tuber.

Authors:  C L Preisig; J A Kuć
Journal:  Plant Physiol       Date:  1987-07       Impact factor: 8.340

4.  Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products.

Authors:  F R DeRubertis; P A Craven; R Saito
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Toxicodynamics of tumour promoters of mouse skin. II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemoluminescence in mouse peritoneal neutrophils.

Authors:  M Hergenhahn; U Kloz; M Fellhauer; G L Tremp; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Prostacyclin production by the deendothelialized rabbit aorta.

Authors:  J M Boeynaems; N Galand; P Ketelbant
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.

Authors:  N K Boughton-Smith; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

8.  Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.

Authors:  N K Boughton-Smith; A M Deakin; R L Follenfant; B J Whittle; L G Garland
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Physiological aspects of free-radical reactions.

Authors:  I Yamazaki; M Tamura; R Nakajima; M Nakamura
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.